Kymeris
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
22 Adelaide St W, Toronto, Ontario, M5H ...Phone Number
(305) 432-4808Website
www.kymerisrx.comRevenue
$5.1 MillionIndustry
About Kymeris
Is Kymeris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Kymeris recently announced quarterly report
Funding: Get notified immidiatlly once Kymeris has new funding data
Check if Kymeris has recently received funding, and reach out quickly before it becomes old news!
Kymeris, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kymeris had a recent Job posting/layoffs
Product Launch: Get notified when Kymeris launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Kymeris is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Kymeris
Recommended Actions
Find VP level buyers at Kymeris
Find more new buyers
Compare Similar Companies to Kymeris
Compare insights from companies similar to Kymeris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kymeris
Company Profile Activity
Activity Insights
Kymeris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kymeris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kymeris.
Kymeris Tech Stack
A closer look at the technologies used by Kymeris
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Kymeris
Kymeris Therapeutics is a pre-clinical immuno-oncology company focused on enhancing cure rates for solid cancers through its innovative platform technology. The company specializes in delivering complex molecular therapies directly into tumors by reprogramming the tumor microenvironment to become immune-competent. With a unique ability to preferent... Read More